Market Place
Sourcing Support
Medimetriks` MM36 Development Program Streamlined Following FDA Meeting
18 Sep 2020 //
BIOSPACE
Medimetriks Announces that Otsuka Achieved +ve Top-Line Ph3 Results for MM36
26 Mar 2020 //
PRNEWSWIRE
Medimetriks Pharmaceuticals, Inc. Submits NDA to FDA for Ozenoxacin Cream
28 Jun 2016 //
PR NEWSWIRE
Otsuka Licenses Pre-Phase 3 Topical Atopic Dermatitis Treatment to Medimetriks
08 Feb 2016 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.